Search Within

Lisa Bodei

  1. "Sloan Kettering Institute Postdocs"
Formats
  1. Meeting Abstract (68)
  2. Journal Article (60)
  3. Review (33)
  4. Book Section (17)
  5. Editorial (12)
  6. Guidelines (9)
  7. Conference Paper (2)
  8. Miscellaneous (2)
  9. Book Whole (1)
  10. Correspondence (1)
Groups
  1. Molecular Imaging and Therapy Service (205)
  2. Radiology, Department of (205)
  3. Sloan Kettering Institute Postdocs (205)
  4. Center for Pancreatic Cancer Research (35)
  5. Department of Medicine (31)
  6. Solid Tumor Oncology Division (29)

More Groups

People
  1. Heiko Schoder (19)
  2. Jason Lewis (18)
  3. Diane Reidy (17)
  4. Joseph O'Donoghue (13)
  5. Simone Krebs (10)
  6. Michael Morris (9)

More People

Years
  1. 2025 (3)
  2. 2024 (15)
  3. 2023 (26)
  4. 2022 (16)
  5. 2021 (27)
  6. 2020 (31)

More Years

Publications
  1. Journal of Nuclear Medicine (34)
  2. Neuroendocrinology (32)
  3. European Journal of Nuclear Medicine and Molecular Imaging (26)
  4. Pancreas (16)
  5. Journal of Clinical Oncology (13)
  6. Radiopharmaceutical Therapy (9)

More Publications

Publishers
  1. Springer (48)
  2. Society of Nuclear Medicine (34)
  3. S. Karger AG (32)
  4. Lippincott Williams & Wilkins (22)
  5. American Society of Clinical Oncology (13)
  6. Elsevier Inc. (11)

More Publishers

Results (205)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Optimized segmentation of neuroendocrine tumor lesions on somatostatin receptor PET/CT imaging for therapy response assessment
    Meeting Abstract

    Chaban, A.; Brosch-Lenz, J.; Song, Y.; Dinkel, V.; Bodei, L.; Weber, W.
    European Journal of Nuclear Medicine and Molecular Imaging (2023)

    Fulltext@MSK | Save
  • Lesion dosimetry for [(177)Lu]Lu-PSMA-617 radiopharmaceutical therapy combined with stereotactic body radiotherapy in patients with oligometastatic castration-sensitive prostate cancer
    Journal Article

    Grkovski, M.; O'Donoghue, J. A.; Imber, B. S.; Andl, G.; Tu, C.; Lafontaine, D.; Schwartz, J.; Thor, M.; Zelefsky, M. J.; Humm, J. L.; more...
    Journal of Nuclear Medicine (2023)

    Fulltext@MSK | Save
  • A phase 1, open-label, dose-ascending study to evaluate the safety and tolerability of the therapeutic radiopharmaceutical (131)I-MIP-1095 for the treatment of metastatic castration-resistant prostate cancer
    Journal Article

    Laccetti, A. L.; Bodei, L.; O'Donoghue, J. A.; Weber, W. A.; Morris, M. J.
    Clinical Nuclear Medicine (2023)

    Fulltext@MSK | Save
  • A pilot study of stereotactic body radiotherapy and (177)Lu-PSMA-617 for oligometastatic hormone sensitive prostate cancer
    Meeting Abstract

    Imber, B. S.; Bodei, L.; Humm, J.; Ionescu, A.; Wu, W.; Grkovski, M.; O'Donoghue, J.; Reddy, R. P.; Rimner, A.; Shasha, D.; more...
    International Journal of Radiation Oncology, Biology, Physics (2023)

    Fulltext@MSK | Save
  • Consensus report of the 2021 National Cancer Institute neuroendocrine tumor clinical trials planning meeting
    Editorial

    Singh, S.; Hope, T. A.; Bergsland, E. B.; Bodei, L.; Bushnell, D. L.; Chan, J. A.; Chasen, B. R.; Chauhan, A.; Das, S.; Dasari, A.; more...
    JNCI: Journal of the National Cancer Institute (2023)

    Fulltext@MSK | Save
  • SNMMI consensus statement on patient selection and appropriate use of (177)Lu-PSMA-617 radionuclide therapy
    Guidelines

    Hope, T. A.; Antonarakis, E. S.; Bodei, L.; Calais, J.; Iravani, A.; Jacene, H.; Koo, P. J.; Morgans, A. K.; Osborne, J. R.; Tagawa, S. T.; more...
    Journal of Nuclear Medicine (2023)

    Fulltext@MSK | Save
  • FRONTIER: FAPi radioligand open-label, phase 1 study to evaluate safety, tolerability and dosimetry of [Lu-177]-PNT6555—A dose escalation study for treatment of patients with select solid tumors
    Meeting Abstract

    Bodei, L.; Kavan, P.; Liberman, M.; Taunk, N.; Metser, U.; Juneau, D.; O'Reilly, E. M.; Ma, J.; Cioci, R.; Abdul Razak, A. R.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Joint EANM/SNMMI procedure guideline for the use of (177)Lu-labeled PSMA-targeted radioligand-therapy ((177(Lu-PSMA-RLT)
    Guidelines

    Kratochwil, C.; Fendler, W. P.; Eiber, M.; Hofman, M. S.; Emmett, L.; Calais, J.; Osborne, J. R.; Iravani, A.; Koo, P.; Lindenberg, L.; more...
    European Journal of Nuclear Medicine and Molecular Imaging (2023)

    Fulltext@MSK | Save
  • Interim analysis of a prospective validation of 2 blood-based genomic assessments (PPQ and NETest) to determine the clinical efficacy of (177)Lu-DOTATATE in neuroendocrine tumors
    Journal Article

    Bodei, L.; Raj, N.; Do, R. K.; Mauguen, A.; Krebs, S.; Reidy-Lagunes, D.; Schöder, H.
    Journal of Nuclear Medicine (2023)

    Fulltext@MSK | Save
  • Neuroendocrine tumor therapy response assessment
    Review

    Jayaprakasam, V. S.; Bodei, L.
    PET Clinics (2023)

    Fulltext@MSK | Save